|
Model Number 6DIC |
Device Problem
Obstruction of Flow (2423)
|
Patient Problems
Dyspnea (1816); Hemorrhage/Bleeding (1888); Insufficient Information (4580)
|
Event Date 02/01/2020 |
Event Type
Death
|
Event Description
|
According to the reporter, the patient had the device inserted in (b)(6) 2020.The tube was used during homecare for 1.5 months.The patient had obstruction from fluids.There was mucus with each cough.The patient needed suction every hour.There was difficulty with the device for 3 months.A replacement device may have been used.The patient passed away.The patient had a diagnosis of traumatic brain injury.
|
|
Manufacturer Narrative
|
If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
According to the reporter, the patient had increased fluids in the lungs and bilateral pneumonia when the physician placed the tracheostomy tube's inner cannula into the patient's throat in (b)(6) 2020.The tube was used during homecare for 1.5 months.The patient had obstruction from fluids and "bleeding around the tube, on and off at different times, resulting in several trips back and forth to the emergency room".There was mucus with each cough.The patient had secretions and needed suction every hour.The patient was not treated with antibiotics.The device was in place for approximately 3 months and there was difficulty with the device for 3 months.The patient passed away.It was reported that the cause of death on the patient's death certificate was listed as "mva".The patient had a diagnosis of traumatic brain injury, secondary to a motor vehicle accident (mva) since the age of 8 yrs old.The patient was cared for by the patient¿s mother up to the time of his death.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Medtronic conducted an investigation based upon all information received.The device was not returned, but a photo was available for evaluation.It was reported that the product had an obstruction.The reported issue could not be confirmed.The most likely cause could not be established from the information available.The manufacturing records for each device are thoroughly reviewed prior to release to ensure that it meets all medtronic quality specifications.A secondary review of the device history records found no potentially contributing factors.The instructions included with this device provide the following guidance: the shiley tracheostomy tube is classified as a disposable medical device.Frequent and routine changes of the tracheostomy tube are recommended.The manufacturer recommends that the tracheostomy tube usage not exceed twenty-nine (29) days.Frequent and routine changes of the tracheostomy tube and accessories are recommended and should be evaluated by the attending physician.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
According to the reporter, the patient had increased fluids in the lungs and bilateral pneumonia when the physician placed the tracheostomy tube's inner cannula into the patient's throat in (b)(6) 2020.The tube was used during homecare for 1.5 months.The patient had obstruction from fluids and "bleeding around the tube, on and off at different times, resulting in several trips back and forth to the emergency room" every 2 weeks.There was mucus with each cough and difficulty breathing.The patient had secretions and needed suction every hour.The patient was not treated with antibiotics.The device was in place for approximately 3 months and there was difficulty with the device for 3 months.The patient passed away after 4 months.It was reported that the cause of death on the patient's death certificate was listed as "mva".The patient had a diagnosis of traumatic brain injury, secondary to a motor vehicle accident (mva) since the age of 8 years old.The patient was cared for by the patient¿s mother up to the time of his death.
|
|
Manufacturer Narrative
|
Additional information: b5, e1, g1, g3, g6, h2, h6.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Search Alerts/Recalls
|
|
|